Welcome to our dedicated page for Futurefuel SEC filings (Ticker: FF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
FutureFuel Corp. SEC filings document material events for a NYSE-listed manufacturer of custom and performance chemicals and biofuels. Recent 8-K reports include operating and financial results for the chemicals and biofuels segments, furnished earnings releases, dividend declarations, share repurchase program disclosures, and other corporate communications filed as exhibits.
The company’s filings also record governance and shareholder matters, including board appointments, chair and lead independent director roles, annual meeting voting results, director elections, auditor ratification, common stock exchange listing information, and related Inline XBRL cover-page data.
FutureFuel Corp. reported sharply higher sales but continued losses for the first quarter of 2026. Revenue rose to $32.0 million, up 82.2% from $17.5 million a year earlier, driven by 61.6% higher volumes and a 20.6% increase in average prices across both Chemicals and Biofuels.
The company posted a net loss of $20.6 million compared with a $18.1 million loss last year, as Winter Storm Fern disruptions and a $9.1 million realized derivatives loss contributed to a gross loss of $15.9 million. Adjusted EBITDA improved to a loss of $13.8 million from a loss of $16.1 million. Chemicals revenue more than doubled to $19.6 million and Biofuels revenue grew 50.7% to $12.3 million. Cash and equivalents fell to $22.4 million from $51.3 million at year-end, with operating cash outflow of $20.0 million and capital spending of $7.1 million. Management expects favorable regulatory changes and customer-funded investments to support positive full-year 2026 Adjusted EBITDA, excluding certain non-cash derivative impacts.
FutureFuel Corp. reported first-quarter 2026 revenue of $31.9 million, up sharply from $17.5 million a year earlier, but still posted a net loss of $20.6 million or $0.47 per share.
Adjusted EBITDA improved to a loss of $13.8 million from a loss of $16.1 million, helped by strong growth in the chemicals segment, including new energy-market products. Biofuels revenue rose, but derivative losses of $11.6 million and non-recurring Winter Storm Fern costs of $1.4 million weighed on margins.
The company ended the quarter with $22.4 million in cash, negative operating cash flow of $20.0 million, and no borrowings under a $35 million revolving credit facility. FutureFuel also changed its inventory accounting from LIFO to weighted average cost and continued to benefit from the Clean Fuel Production Credit.
FutureFuel Corp. filed an 8-K to announce the timing of its next earnings release. The company plans to publish financial results for the first quarter ended March 31, 2026 after the market close on Monday, May 11, 2026, with details available in the Investor Relations section of its website.
FutureFuel describes itself as a manufacturer of diversified chemical products and biofuels, including custom and performance specialty chemicals, as well as biodiesel sold through its biofuels segment.
FutureFuel Corp. announced a change in its capital return strategy, cutting its quarterly dividend to $0.01 per share starting with the second quarter of 2026. The dividend is payable to shareholders of record on June 4, 2026, with payment on June 18, 2026.
The Board plans to redirect capital previously used for dividends toward funding growth projects and opportunistic share repurchases under a reaffirmed $25 million buyback authorization. Management and the Board state they believe FutureFuel’s shares are undervalued and expect increased investment in the chemicals segment to improve margins and accelerate growth.
FutureFuel Corp. director Ronald J. Kruszewski received a grant of stock options as part of his compensation. He was awarded 10,000 options to buy FutureFuel common stock at an exercise price of $3.7700 per share, bringing his total reported option holdings in this grant to 10,000 options.
The options were granted under the FutureFuel Corp. 2017 Omnibus Incentive Plan and are subject to its terms and an applicable option agreement. They become exercisable starting on March 18, 2026 and remain exercisable until their expiration on March 18, 2031. This is a compensation-related award, not an open-market stock purchase or sale.
FutureFuel Corp. director Rowe Richard P. received a grant of stock options covering 10,000 shares of common stock. The options have an exercise price of $3.77 per share and were awarded with no cash paid at grant.
The options were granted under the FutureFuel Corp. 2017 Omnibus Incentive Plan and may be exercised from March 18, 2026 until they expire on March 18, 2031. After this grant, Rowe holds 10,000 stock options directly according to the filing.
FutureFuel Corp. director Manheim Paul received a grant of stock options, not an open-market purchase. He was awarded 10,000 stock options for FutureFuel Corp. common stock on March 18, 2026, at an exercise price of $3.77 per share. These options were granted under the company’s 2017 Omnibus Incentive Plan as compensation and may be exercised between March 18, 2026 and March 18, 2031. After this grant, his reported derivative holdings from this filing total 10,000 options.
FutureFuel Corp. director Pamela R. Butcher received a grant of stock options covering 10,000 shares of common stock. The options have an exercise price of 3.7700 per share and were issued under the FutureFuel Corp. 2017 Omnibus Incentive Plan.
The options may be exercised beginning on March 18, 2026 and remain exercisable until March 18, 2031. Following this grant, the filing shows Butcher holding 10,000 stock options directly as part of her equity-based compensation.
FutureFuel Corp. director Paul Anthony Novelly II received a grant of stock options representing 10,000 shares of common stock. The options have an exercise price of $3.77 per share and were awarded under the company’s 2017 Omnibus Incentive Plan as equity-based compensation.
The options may be exercised starting on March 18, 2026 and remain exercisable until their expiration on March 18, 2031. Following this grant, Novelly holds stock options covering 10,000 shares directly, aligning his incentives with the long-term performance of FutureFuel’s stock.
FutureFuel Corp. director Greer GBruce received a grant of stock options covering 10,000 shares of common stock. The options have an exercise price of $3.77 per share and were awarded under the company’s 2017 Omnibus Incentive Plan as compensation, not through open-market buying or selling. They may be exercised beginning on March 18, 2026 and will expire on March 18, 2031 if not used.